arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Rafael Holdings, Inc.

RFL
$2.08 ▲ +0.09 (+4.77%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
11 Visible periods
28 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

Rafael Holdings, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $61.2M
Dividend Yield
Revenue Growth 44.0%
Op. Margin None
ROIC -28.5%
FCF / Share $-0.64
Trailing P/E
Price / Book 0.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

11-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$917.00K
↑ +44.0%
Net Income Profit after all expenses
$-30.52M
↑ +11.3%
Operating Margin Operating profit as % of sales
-172.4%
↓ -27.0%
FCF / Share Free cash flow per share
$-0.64
↓ -92.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns
22
Financial Health
18
Cash Quality
45

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 41 quarters